Primaquine to reduce transmission of Plasmodium falciparum malaria in Mali: a single-blind, dose-ranging, adaptive randomised phase 2 trial
Alassane Dicko(University of Bamako), Roly Gosling(University of California, San Francisco), Eugenie Poirot(New York City Department of Health and Mental Hygiene), Halimatou Diawara(Université des Sciences, des Techniques et des Technologies de Bamako), Teun Bousema(Radboud University Nijmegen), Harouna M Soumaré(Centre National de la Recherche Scientifique), Joelle Brown(University of California, San Francisco), Mikko Niemi(University of Helsinki), Helmi Pett(University of Helsinki), Ingrid Chen(University of California, San Francisco), Kjerstin Lanke(Radboud University Medical Center), Ibrahima Baber(University of Bamako), Jimee Hwang(Centers for Disease Control and Prevention), Almahamoudou Mahamar(Centre National de la Recherche Scientifique), Sekouba Keita, Sékou F. Traorè, Koualy Sanogo, Charles E. McCulloch(University of California, San Francisco), François Nosten(Mahidol Oxford Tropical Medicine Research Unit), Fanta Koïta(University of Bamako)
Cited by 98
Related Papers
Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization
|New England Journal of Medicine|2004|11.4k
Functional Status of Elderly Adults before and after Initiation of Dialysis
|New England Journal of Medicine|2009|1k
Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease
|Kidney International|2009|570
International estimated fetal weight standards of the <scp>INTERGROWTH</scp>‐21<sup>st</sup> Project
|Ultrasound in Obstetrics and Gynecology|2017|358
Targeting Asymptomatic Malaria Infections: Active Surveillance in Control and Elimination
|PLoS Medicine|2013|356